A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2509-2723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A retrotransposon storm marks clinical phenoconversion to late-onset Alzheimer’s disease ; volume:44 ; number:3 ; day:19 ; month:5 ; year:2022 ; pages:1525-1550 ; date:6.2022
GeroScience ; 44, Heft 3 (19.5.2022), 1525-1550, 6.2022
- Urheber
-
Macciardi, Fabio
Giulia Bacalini, Maria
Miramontes, Ricardo
Boattini, Alessio
Taccioli, Cristian
Modenini, Giorgia
Malhas, Rond
Anderlucci, Laura
Gusev, Yuriy
Gross, Thomas J.
Padilla, Robert M.
Fiandaca, Massimo S.
Head, Elizabeth
Guffanti, Guia
Federoff, Howard J.
Mapstone, Mark
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11357-022-00580-w
- URN
-
urn:nbn:de:101:1-2022081411325484323563
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Macciardi, Fabio
- Giulia Bacalini, Maria
- Miramontes, Ricardo
- Boattini, Alessio
- Taccioli, Cristian
- Modenini, Giorgia
- Malhas, Rond
- Anderlucci, Laura
- Gusev, Yuriy
- Gross, Thomas J.
- Padilla, Robert M.
- Fiandaca, Massimo S.
- Head, Elizabeth
- Guffanti, Guia
- Federoff, Howard J.
- Mapstone, Mark
- SpringerLink (Online service)
Ähnliche Objekte (12)
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease
Exploring the role of common regulatory variants in the etiology of late-onset Alzheimer’s disease
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups
Early and late-onset Alzheimer’s disease: What are the differences?
Late-onset Alzheimer’s disease is associated with inherent changes in bioenergetics profiles
Evaluation of Animal Models by Comparison with Human Late-Onset Alzheimer’s Disease
Benchmarking machine learning models for late-onset alzheimer’s disease prediction from genomic data
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Medial temporal lobe atrophy patterns in early-versus late-onset amnestic Alzheimer’s disease
Targeting Neural Hyperactivity as a Treatment to Stem Progression of Late-Onset Alzheimer’s Disease
Paroxetine ameliorates prodromal emotional dysfunction and late-onset memory deficit in Alzheimer’s disease mice
A novel systems biology approach to evaluate mouse models of late-onset Alzheimer’s disease